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Hepatic VLDL assembly is proposed as a two-step process in which a small primordial lipoprotein particle is formed in the smooth
ER by cotranslational lipidation of apolipoprotein B (APOB) by the lipid transfer chaperone microsomal triglyceride transfer
protein (MTTP) (1). The nascent VLDL particles are progressively lipidated (step 2) through fusion with ER lipid droplets in a process
that requires MTTP and other players, including TM6SF2 (1). Because MTTP is required for both step 1 and step 2, mice with liver-
specific deletion of Mttp (Mttp-LKO) develop hepatic steatosis and complete abrogation of VLDL and APOB secretion (2). Both
germline (3) and liver-specific Tm6sf2 deletor mice (Tm6sf2-LKO, Tm6sf2f/f Albumin CreTg) (4) exhibit steatosis and reduced VLDL
triglyceride, but no change in APOB secretion (even in an APOB100-only background (4)), consistent with secretion of small and
underlipidated VLDL particles in Tm6-LKO mice (3, 4). We used transmission electron microscopy to visualize intracellular and
nascent lipoprotein particles in the ER and Golgi of Mttp-LKO, Tm6sf2-LKO, and Flox control mice. Lipoprotein particles, which
appear translucent in the absence of imidazole-buffered osmium staining (2), were observed in Golgi of control and Tm6sf2-LKO
mice (arrowheads, left and middle panels), but none were detected in the ER or Golgi of Mttp-LKO mice, with Golgi stacks
appearing either flat or dilated, with no distinct structures inside (right). Nascent VLDL particles in Tm6sf2-LKO Golgi were smaller
compared with controls (lower left, n = 68–74 particles/genotype; ImageJ software; NIH). Relative VLDL secretion rate is shown for
each genotype (lower right).
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EQUIPMENT: Leica EM UC7 ultramicrotome (Leica-Microsystems, Vienna, Austria) and JEM-1400 transmission electron microscopy
(JEOL, Peabody, MD) with an AMT XR111 8 Megapixel scintillated CCD camera.
METHODS: Livers were perfused in situ (2.5% glutaraldehyde, 2% paraformaldehyde, 2 mM CaCl2 in 0.15 M cacodylate buffer,
5 min), excised, and fixed overnight in fresh fixative. The tissue was postfixed (1% osmium tetroxide and 0.3% potassium ferro-
cyanide in 0.15 M cacodylate), washed, and stained en bloc with 2% aqueous uranyl acetate (overnight, 4◦C). Tissues were dehydrated
in 30%, 50%, 70%, and 100% (3×) ethanol, infiltrated in a Spurr's resin/ethanol-graded series, embedded in 100% Spurr's resin, and
polymerized at 60◦C for 48 h. About 70 nm ultrathin sections were picked up on copper formvar/carbon support film grids and
poststained with 1% tannic acid (2 min), 1% osmium tetroxide (2 min), 2% uranyl acetate (15 min), and Sato's lead for 2 min. Serum
triglyceride was measured at 0 and 4 h after injection with Pluronic F-127 (10 μl/g body weight) to examine VLDL secretion.
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